Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

99.66 +0.28 (+0.29%)
Delayed Quote Updated: 1:49 PM EST, Nov 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
23 24 Next >
News headline image
Edwards Lifesciences to Host Earnings Conference Call on October 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Kaplan Fox & Kilsheimer LLP Alerts Investors to a Securities Class Action Against Edwards Lifesciences Corp. (EW) - Deadline is December 13, 2024
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
Kaplan Fox &amp; Kilsheimer LLP Alerts Investors to a Securities Class Action Against Edwards Lifesciences Corp. (EW) - Deadline is December 13, 2024
NEW YORK, NY - (NewMediaWire) - October 16, 2024 - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Edwards Lifesciences Corporation (“Edwards Lifesciences” or... 
Via TheNewswire.com
Topics Lawsuit
News headline image
Edwards Lifesciences Corporation (EW) Investors: December 13, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
News headline image
A Closer Look at 25 Analyst Recommendations For Edwards Lifesciences ↗
 
Via Benzinga
News headline image
EDWARDS LIFESCIENCES CORPORATION (NYSE: EW) INVESTOR ALERT: Investors With Large Losses in Edwards Lifesciences Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Edwards Lifesciences Corporation
From Robbins LLP
Via GlobeNewswire
News headline image
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
News headline image
Analyst Scoreboard: 19 Ratings For Edwards Lifesciences ↗
 
Via Benzinga
News headline image
Peering Into Edwards Lifesciences's Recent Short Interest ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
EW Investors Have Opportunity to Lead Edwards Lifesciences Corporation Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
The Law Offices of Frank R. Cruz Announces Investigation of Edwards Lifesciences Corporation (EW) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
How Is The Market Feeling About Edwards Lifesciences? ↗
 
Via Benzinga
News headline image
If You Invested $100 In This Stock 20 Years Ago, You Would Have $2,200 Today ↗
 
Via Benzinga
News headline image
EDWARDS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Edwards Lifesciences Corp and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Rosen Law Firm Urges Edwards Lifesciences Corporation (NYSE: EW) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
EW INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Edwards Lifesciences Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
News headline image
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Edwards Lifesciences Corporation
From Faruqi & Faruqi LLP
Via GlobeNewswire
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Edwards Lifesciences Completes Sale of Critical Care
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
CORRECTING and REPLACING First All-Female TAVI Trial Shows Excellent Outcomes for Women Receiving Edwards Valves
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
This Is Great News for Medtronic, but Is It Time to Buy the Stock? ↗
This MedTech leader is back on track with profitable growth. 
Via The Motley Fool
News headline image
Edwards Lifesciences to Present at the 2024 Wells Fargo Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
9 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Top 3 Health Care Stocks That Are Set To Fly This Quarter ↗
 
Via Benzinga
News headline image
7 Leading MedTech Stocks for Next-Gen Health Solutions ↗
With healthcare innovations promising to deliver groundbreaking solutions, these MedTech stocks should be on your radar. 
Via InvestorPlace
News headline image
Jim Cramer Says This Home Improvement Chain Is A Buy Ahead Of Fed Rate Cut Cycle: 'I Would Pick Some Up Tomorrow' ↗
Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit from Federal Reserve's rate cut. 
Via Benzinga
Topics Economy
News headline image
Top 3 Health Care Stocks That May Explode In Q3 ↗
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.